Anne van Beveren

Anne Van Beveren has extensive experience in market access and reimbursement roles within the pharmaceutical and medical device industries. Anne is currently working as the Director of Market Access and Reimbursement at CeQur. Prior to this, they served as the Director of National Accounts at Emergent BioSolutions from 2020 to 2021. From 2018 to 2020, Anne worked as the Corporate Account Director at Scilex Pharmaceuticals, where they successfully developed and implemented market access strategies, securing coverage for a significant portion of the US population. Before Scilex Pharmaceuticals, they held the role of Corporate Account Director at Questcor/Mallinckrodt Pharmaceuticals from 2014 to 2018. In this role, they contracted and implemented pull-through strategies for key health plan and pharmacy benefit manager accounts, earning multiple awards for their performance. Anne also worked as the Director of Healthcare Strategies at Aerocrine from 2013 to 2014, where they focused on securing profitable access for the company's medical devices. Anne'scareer in the pharmaceutical industry began at Sanofi in 2001, where they held various roles including Government Account Executive, National Account Manager, and Regional Account Manager, working with managed care organizations and health plans. Overall, Anne Van Beveren has a proven track record of success in market access and reimbursement, achieving coverage goals and building strong relationships with key stakeholders.

Anne Van Beveren obtained a Master of Arts (M.A.) degree in Mass Communication/Media Studies from California State Northridge. Anne also holds a Master of Arts (M.A.) degree in Mass Communication from California State University Northridge, which they completed in 1997.